PROFESSIONAL EDITION

The largest community of pharma leaders

Lygos and Open Book Extracts Sign MOU to Co-Develop and Commercialize Nutraceutical Supplement Products Containing Rare Cannabinoids

BERKELEY, Calif.–(BUSINESS WIRE)– #biobased–Lygos and Open Book Extracts to co-develop and commercialize nutraceutical supplement products containing rare cannabinoids

Source

Recent Articles